Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
atropine (OT-101 ophthalmic solution) / Ocumension Therap
NCT06697522: Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children	Completed	3	148	RoW	Atropine Sulfate, Investigational product, Placebo, Blank Solvent	Ocumension Therapeutics (Suzhou) Co., Ltd, Beijing Children's Hospital	Myopia	10/23	03/24
NCT04770610 / 2020-003976-42: Study of OT-101 in Treating Myopia	Active, not recruiting	3	678	US	OT-101 Ophthalmic Solution, Investigational Product, Vehicle, Placebo	Ocumension (Hong Kong) Limited, ORA, Inc., Statistics & Data Corporation	Myopia, Progressive	03/27	04/27